- Bionoid Pharma (OTCPK:BINP) said it will rebrand itself as AI Maverick Intel as the firm looks to use advanced artificial intelligence technologies to boost customer acquisition and engagement across healthcare, biotech, and other sectors.
- The firm added that the rebranding comes after the acquisition of AI Maverick Intel.